These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 9849264)

  • 21. Lactobacillus paracasei strain ST11 has no effect on rotavirus but ameliorates the outcome of nonrotavirus diarrhea in children from Bangladesh.
    Sarker SA; Sultana S; Fuchs GJ; Alam NH; Azim T; Brüssow H; Hammarström L
    Pediatrics; 2005 Aug; 116(2):e221-8. PubMed ID: 15995003
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical consequences of rotavirus acute gastroenteritis in Europe, 2004-2005: the REVEAL study.
    Giaquinto C; Van Damme P; Huet F; Gothefors L; Maxwell M; Todd P; da Dalt L;
    J Infect Dis; 2007 May; 195 Suppl 1():S26-35. PubMed ID: 17387649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rotavirus vaccines and intussusception risk.
    Bines JE
    Curr Opin Gastroenterol; 2005 Jan; 21(1):20-5. PubMed ID: 15687880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improving rehydration solutions with human milk proteins: are the benefits worth the challenges?
    Abrams SA; Hilmers DC
    J Pediatr Gastroenterol Nutr; 2007 Mar; 44(3):298-9. PubMed ID: 17325548
    [No Abstract]   [Full Text] [Related]  

  • 25. New vaccines for infectious diseases.
    Waterman S; Fritz C
    West J Med; 1998 Dec; 169(6):370-1. PubMed ID: 9866435
    [No Abstract]   [Full Text] [Related]  

  • 26. Protective effects of natural rotavirus infection.
    Velázquez FR
    Pediatr Infect Dis J; 2009 Mar; 28(3 Suppl):S54-6. PubMed ID: 19252424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The new pentavalent rotavirus vaccine composed of bovine (strain WC3) -human rotavirus reassortants.
    Clark HF; Offit PA; Plotkin SA; Heaton PM
    Pediatr Infect Dis J; 2006 Jul; 25(7):577-83. PubMed ID: 16804425
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rotavirus serotypes: classification and importance in epidemiology, immunity, and vaccine development.
    Hoshino Y; Kapikian AZ
    J Health Popul Nutr; 2000 Jun; 18(1):5-14. PubMed ID: 11014764
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The first rotavirus vaccine approved in the USA and Europe].
    Svensson L; Johansen K; Uhnoo I
    Lakartidningen; 1999 Jun; 96(26-27):3158-60. PubMed ID: 10423974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Trends in research in developing new type of vaccines--aiming at efficacy and safety. Rotavirus vaccines].
    Urasawa S
    Nihon Rinsho; 1987 Oct; 45(10):2415-20. PubMed ID: 2834580
    [No Abstract]   [Full Text] [Related]  

  • 31. Safety, efficacy, and immunogenicity of 2 doses of bovine-human (UK) and rhesus-rhesus-human rotavirus reassortant tetravalent vaccines in Finnish children.
    Vesikari T; Karvonen AV; Majuri J; Zeng SQ; Pang XL; Kohberger R; Forrest BD; Hoshino Y; Chanock RM; Kapikian AZ
    J Infect Dis; 2006 Aug; 194(3):370-6. PubMed ID: 16826486
    [TBL] [Abstract][Full Text] [Related]  

  • 32. RotaTeq: a three-dose oral pentavalent reassortant rotavirus vaccine.
    Chandran A; Santosham M
    Expert Rev Vaccines; 2008 Dec; 7(10):1475-80. PubMed ID: 19053204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral rehydration solution therapy in the management of children with rotavirus diarrhea.
    Nappert G; Barrios JM; Zello GA; Naylor JM
    Nutr Rev; 2000 Mar; 58(3 Pt 1):80-7. PubMed ID: 10812923
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The current status of the rotavirus vaccine.
    Jacobson RM
    Vaccine; 1999 Mar; 17(13-14):1690-9. PubMed ID: 10194824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rotavirus vaccines--an update.
    Dennehy PH
    Vaccine; 2007 Apr; 25(16):3137-41. PubMed ID: 17321017
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Rotavirus vaccines: targeting the developing world.
    Glass RI; Bresee JS; Turcios R; Fischer TK; Parashar UD; Steele AD
    J Infect Dis; 2005 Sep; 192 Suppl 1():S160-6. PubMed ID: 16088799
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rotavirus serotype G9 is associated with more-severe disease in Latin America.
    Linhares AC; Verstraeten T; Wolleswinkel-van den Bosch J; Clemens R; Breuer T
    Clin Infect Dis; 2006 Aug; 43(3):312-4. PubMed ID: 16804845
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Assessing the effectiveness and public health impact of rotavirus vaccines after introduction in immunization programs.
    Patel MM; Parashar UD
    J Infect Dis; 2009 Nov; 200 Suppl 1():S291-9. PubMed ID: 19817612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Expression of Toll-like receptors in mononuclear cells from children with acute rotavirus diarrhea].
    Xu J; Yang Y; Sun JE; Ding YZ; Su LY; Shao CH
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2007 Mar; 21(1):38-40. PubMed ID: 17429531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.
    Phua KB; Quak SH; Lee BW; Emmanuel SC; Goh P; Han HH; De Vos B; Bock HL
    J Infect Dis; 2005 Sep; 192 Suppl 1():S6-S16. PubMed ID: 16088807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.